| [1] |
ASGE Standards of Practice Committee, Chathadi KV, Chandrasekhara V, et al. The role of ERCP in benign diseases of the biliary tract[J]. Gastrointest Endosc, 2015, 81(4):795-803.
|
| [2] |
Yao S, Taura K, Okuda Y, et al. Effect of mapping biopsy on surgical management of cholangiocarcinoma[J]. J Surg Oncol, 2018, 118(6): 997-1005.
|
| [3] |
ASGE Standards of Practice Committee, Chathadi KV, Khashab MA, et al. The role of endoscopy in ampullary and duodenal adenomas[J]. Gastrointest Endosc, 2015, 82(5):773-781.
|
| [4] |
Pea A, Riva G, Bernasconi R, et al. Ampulla of Vater carcinoma: molecular landscape and clinical implications[J]. World J Gastrointest Oncol, 2018, 10(11):370-380.
|
| [5] |
Yamamoto K, Itoi T, Sofuni A, et al. Expanding the indication of endoscopic papillectomy for T1a ampullary carcinoma[J]. Dig Endosc, 2019, 31(2):188-196.
|
| [6] |
Sakai A, Tsujimae M, Masuda A, et al. Clinical outcomes of ampullary neoplasms in resected margin positive or uncertain cases after endoscopic papillectomy[J]. World J Gastroenterol, 2019, 25(11):1387-1397.
|
| [7] |
Camus M, Napoléon B, Vienne A, et al. Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy:a multicenter prospective study[J]. Gastrointest Endosc, 2018, 88(3):511-518.
|
| [8] |
Hu B, Sun B, Gao DJ, et al. Initial experience of ERCP-guided radiofrequency ablation as the primary therapy for inoperable ampullary carcinomas[J]. Dig Dis Sci, 2019, DOI: 10.1007/s10620-019-05849-3[Epub ahead of print]. |
| [9] |
中华医学会消化内镜学分会ERCP学组，中国医师协会消化医师分会胆胰学组，国家消化系统疾病临床医学研究中心．中国ERCP指南（2018版）[J]．中华内科杂志，2018, 57(11):772-801.
|
| [10] |
Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline-updated October 2017[J]. Endoscopy, 2018, 50(9):910-930.
|
| [11] |
Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J].J Gastroenterol, 2011, 46(2):242-248.
|
| [12] |
Xia MX, Cai XB, Pan YL, et al. Optimal stent placement strategy for malignant hilar biliary obstruction: a large multicenter parallel study[J]. Gastrointest Endosc, 2019, pii:S0016-5107(19)32565-9.
|
| [13] |
Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma[J].J Gastroenterol Hepatol, 2013, 28(4):593-607.
|
| [14] |
Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study[J]. Gastroenterology, 2003, 125(5): 1355-1363.
|
| [15] |
Zoepf T, Jakobs R, Arnold JC, et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy[J]. Am J Gastroenterol, 2005, 100(11):2426-2430.
|
| [16] |
Cheon YK, Cho YD, Baek SH, et al. Comparison of survival of advanced hilar cholangiocarcinoma after biliary drainage alone versus photodynamic therapy with external drainage[J]. Korean J Gastroenterol, 2004, 44(5):280-287.
|
| [17] |
Schmidt A, Bloechinger M, Weber A, et al. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma[J]. United European Gastroenterol J, 2016, 4(4): 570-579.
|
| [18] |
Strand DS, Cosgrove ND, Patrie JT, et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma[J]. Gastrointest Endosc, 2014, 80(5):794-804.
|
| [19] |
Banerjee N, Hilden K, Baron TH, et al. Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction[J]. Dig Dis Sci, 2011, 56(2):591-595.
|
| [20] |
Yang J, Wang J, Zhou H, et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial[J]. Endoscopy, 2018, 50(8): 751-760.
|